Management of Treatment-Experienced Patients With HIV
Summary
- Raltegravir and elvitegravir resistance typically evolves over time, with initial patterns replaced by mutations conferring high level resistance if their use is continued[Fransen 2009]
- Twice-daily doses of dolutegravir have been shown to be effective some of in these patients[Eron 2013a]
Action required
- Login now to access all of your entitled content
or - View additional options to gain access to this content